Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             200 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 135 A CANADIAN MULTI-CENTRED ASSESSMENT OF CANCER PAIN MANAGEMENT USING THE PAIN MANAGEMENT INDEX Mitera, G.
2009
92 S2 p. S43-
1 p.
artikel
2 16 A COMPARISON OF TWO IMMOBILIZATION SYSTEMS FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) OF LUNG TUMOURS Han, K.
2009
92 S2 p. S5-S6
2 p.
artikel
3 110 ACTIVATORS OF AMP-ACTIVATED PROTEIN KINASE (AMPK) ENHANCE RADIATION RESPONSES IN LUNG CANCER CELLS Sanli, T.
2009
92 S2 p. S35-
1 p.
artikel
4 67 ACTIVE SURVEILLANCE WITH SELECTED DELAYED INTERVENTION FOR LOCALIZED PROSTATE CANCER: OUTCOMES AFTER THIRTEEN YEARS OF FOLLOW UP Loblaw, A.
2009
92 S2 p. S21-S22
2 p.
artikel
5 29 ACTUAL UTILIZATION OF RADIOTHERAPY IN RURAL AND URBAN AREAS COMPARED TO EVIDENCE BASED ESTIMATES OF RADIOTHERAPY NEED FOR PATIENTS WITH BREAST, PROSTATE AND LUNG CANCER Tyldesley, S.
2009
92 S2 p. S10-
1 p.
artikel
6 133 ACUTE SIDE EFFECTS OF CAPECITABINE COMPARED TO 5FU FOR CONCURRENT CHEMORADIATION OF RECTAL CANCER: A 5-YEAR REVIEW Haddad, P.
2009
92 S2 p. S42-S43
2 p.
artikel
7 198 A FRAMEWORK FOR MEASURING QUALITY OF CARE: AN ILLUSTRATION IN PROSTATE CANCER Danielson, B.
2009
92 S2 p. S62-S63
2 p.
artikel
8 161 A LARGE ANIMAL MODEL FOR PROSTATE CANCER RESEARCH MIMICKING THE HIGH RISK HUMAN DISEASE Cury, F.
2009
92 S2 p. S51-
1 p.
artikel
9 192 A MULTIDISCIPLINARY SUMMER STUDENTSHIP IN PALLIATIVE AND SUPPORTIVE CARE IN ONCOLOGY Fairchild, A.
2009
92 S2 p. S61-
1 p.
artikel
10 118 ANALYSIS OF THE ACCURACY OF AUTOMATED ATLAS-BASED SEGMENTATION FOR PROSTATE RADIOTHERAPY Bowes, D.
2009
92 S2 p. S38-
1 p.
artikel
11 36 ANALYZING WHETHER PET SCAN PARAMETERS PREDICT FOR PROGRESSION FREE SURVIVAL IN LOCALLY ADVANCED ESOPHAGEAL CANCER Schellenberg, D.
2009
92 S2 p. S12-
1 p.
artikel
12 152 AN EVALUATION OF PATTERNS OF RADIOTHERAPY PRACTICE FOR PATIENTS WITH RIB METASTASES: A SINGLE INSTITUTION STUDY Dalimonte, L.
2009
92 S2 p. S48-
1 p.
artikel
13 146 A NOVEL APPROACH FOR WHOLE SPINE IRRADIATION (WSI) USING A TWO-ISOCENTRE IMRT PLAN WITH FIELD JUNCTIONS Cao, F.
2009
92 S2 p. S47-
1 p.
artikel
14 10 A PHASE III COMPARISON OF PROPHYLACTIC CRANIAL IRRADIATION (PCI) VERSUS OBSERVATION IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LANSCLC). INITIAL RESULTS OF NCIC BR.C1/RTOG 0214 Sun, A.
2009
92 S2 p. S3-S4
2 p.
artikel
15 20 A PHASE I TRIAL OF SIMULTANEOUS IN-FIELD BOOST HELICAL TOMOTHERAPY FOR 1-3 BRAIN METASTASES Bauman, G.
2009
92 S2 p. S7-
1 p.
artikel
16 103 A PILOT PROJECT TO ESTABLISH THE FEASIBILITY OF A POPULATION-BASED PROSTATE CANCER OUTCOMES UNIT WITH RISK FACTOR, DIAGNOSIS, TREATMENT, AND OUTCOME DATA LINKED TO A TUMOUR TISSUE REPOSITORY Ryhorchuk, A.D.
2009
92 S2 p. S33-
1 p.
artikel
17 141 A PILOT STUDY TO INVESTIGATE THE FEASIBILITY OF USING A TOTALLY INTRAVAGINAL STENT TO PREVENT VAGINAL STENOSIS FOLLOWING GYNAECOLOGICAL RADIATION THERAPY Rauth, S.
2009
92 S2 p. S45-
1 p.
artikel
18 57 A POPULATION-BASED STUDY OF FACTORS AFFECTING ACCESS TO RADIOTHERAPY FOR ENDOMETRIAL CANCER IN ONTARIO Hanna, T.P.
2009
92 S2 p. S18-
1 p.
artikel
19 186 APPLICATION OF MACHINE LEARNING METHODOLOGY FOR PETBASED DEFINITION OF LUNG CANCER Kerhet, A.
2009
92 S2 p. S59-
1 p.
artikel
20 167 A PRELIMINARY INVESTIGATION OF TOTAL QUALITY CULTURE IN RADIOTHERAPY DEPARTMENTS ACROSS ONTARIO, CANADA: A PROVINCIAL SURVEY Mitera, G.
2009
92 S2 p. S53-
1 p.
artikel
21 140 A PROSPECTIVE, MULTI-INSTITUTIONAL TRIAL OF IMRT IN HEAD AND NECK CANCER: CLINICAL OUTCOMES AND PATTERNS OF FAILURE Shakam, A.
2009
92 S2 p. S45-
1 p.
artikel
22 106 ARE ‘HIGHER RISK’ BREAST CANCER PATIENTS LESS LIKELY TO BE OFFERED PARTIAL BREAST RADIOTHERAPY TRIAL PARTICIPATION? Parhar, T.
2009
92 S2 p. S34-
1 p.
artikel
23 169 A RETROSPECTIVE QUANTITATIVE ANALYSIS EXAMINING THE CHANGES IN BLADDER VOLUME THROUGHOUT RADIOTHERAPY FOR GYNECOLOGIC PATIENTS Austin, J.
2009
92 S2 p. S53-S54
2 p.
artikel
24 65 ASSESSING RADIATION ONCOLOGY RESIDENTS IN THE CANMEDS ERA: DEVELOPING A MULTI-SOURCE FEEDBACK PROGRAM Giuliani, M.
2009
92 S2 p. S21-
1 p.
artikel
25 82 ASSESSMENT OF INTRA-FRACTION TARGET POSITION ACCURACY FOR LUNG STEREOTACTIC BODY RADIOTHERAPY (SBRT) USING CONE-BEAM CT (CBCT) Li, W.
2009
92 S2 p. S26-S27
2 p.
artikel
26 166 ATTITUDES OF CANADIAN RADIATION ONCOLOGISTS TOWARDS POST-LUMPECTOMY RADIOTHERAPY FOR ELDERLY WOMEN WITH STAGE I HORMONE RESPONSIVE BREAST CANCER Szumacher, E.
2009
92 S2 p. S52-S53
2 p.
artikel
27 AUTHOR INDEX 2009
92 S2 p. S64-S67
4 p.
artikel
28 107 CAN A FALSE NEGATIVE SENTINEL LYMPH NODE BIOPSY BE PREDICTED PRE-OPERATIVELY? Paquette, M.
2009
92 S2 p. S34-
1 p.
artikel
29 33 CAN HIGH DOSE-RATE (HDR) BRACHYTHERAPY BE GIVEN AS A SINGLE FRACTION WHEN USED AS A BOOST WITH EXTERNAL BEAM RADIOTHERAPY (EBRT) TO TREAT PROSTATE CANCER? A COMPARISON OF TWO FRACTIONATION SCHEDULES Morton, G.
2009
92 S2 p. S11-
1 p.
artikel
30 2 CAN THE IMAGES OBTAINED WITH MRI MINIMIZE THE CONTOURING VARIABILITY IN THE POST-OPERATIVE IMAGING OF PATIENTS WITH PROSTATE BRACHYTHERAPY? Usmani, N.
2009
92 S2 p. S1-
1 p.
artikel
31 71 CARDIOVASCULAR MORTALITY (CV) AMONG PROSTATE CANCER PATIENTS (PCa) TREATED RADICALLY WITH EXTERNAL BEAM RADIATION THERAPY (EBRT) WITH AND WITHOUT NEOADJUVANT ANDROGEN DEPRIVATION THERAPY (NADT) Kim, J.
2009
92 S2 p. S23-
1 p.
artikel
32 120 CARE OF BREAST CANCER SURVIVORS: FAMILY PHYSICIAN PERSPECTIVES Smith, S.
2009
92 S2 p. S38-
1 p.
artikel
33 175 CHANGES IN THE USE OF PALLIATIVE RADIOTHERAPY FOR BONE METASTASES IN ONTARIO Sutton, D.
2009
92 S2 p. S55-S56
2 p.
artikel
34 55 CHANGES IN THE USE OF PALLIATIVE RADIOTHERAPY FOR BRAIN METASTASES IN ONTARIO Sutton, D.
2009
92 S2 p. S18-
1 p.
artikel
35 53 CHANGING STRESS WHILE STRESSING CHANGE: THE ROLE OF INTERPROFESSIONAL EDUCATION (IPE) IN MEDIATING STRESS IN THE INTRODUCTION OF A TRANSFORMATIVE TECHNOLOGY SUCH AS IMAGE GUIDED RADIATION THERAPY (IGRT) Gillan, C.
2009
92 S2 p. S17-
1 p.
artikel
36 19 CHANGING UTILIZATION OF RADIATION THERAPY IN LYMPHOID MALIGNANCIES Pickles, T.
2009
92 S2 p. S6-S7
2 p.
artikel
37 173 11C-METHIONINE POSITRON EMISSION TOMOGRAPHY TO ASSESS TREATMENT RESPONSE OF ACOUSTIC NEUROMAS TO STEREOTACTIC IRRADIATION Hsu, F.
2009
92 S2 p. S55-
1 p.
artikel
38 78 COMBINED MR AND CT IMAGING FOR ASSESSING CARDIAC SPARING IN BREAST CANCER TREATMENTS Menon, G.
2009
92 S2 p. S25-
1 p.
artikel
39 31 COMPARATIVE PREDICTIVE VALUE OF E6 MRNA VERSUS HPV16 ISH FOR HUMAN OROPHARYNGEAL CARCINOMA Liu, F.-F.
2009
92 S2 p. S10-
1 p.
artikel
40 3 COMPARISON BETWEEN HIGH AND LOW SOURCE ACTIVITY FOR PERMANENT SEED PROSTATE BRACHYTHERAPY WITH RADIOACTIVE I125 Masucci, G.L.
2009
92 S2 p. S1-S2
2 p.
artikel
41 125 COMPARISON OF A NEW TOMOTHERAPY BASED STEREOTACTIC RADIOSURGERY PLANNING TECHNIQUE AND CONVENTIONAL PLANNING USING CIRCULAR COLLIMATORS Soisson, E.
2009
92 S2 p. S40-
1 p.
artikel
42 5 COMPARISON OF CLINICAL OUTCOME IN INTERMEDIATE RISK PROSTATE CANCER PATIENT TREATED WITH PERMANENT SEEDS IMPLANT ALONE OR EXTERNAL BEAM RADIOTHERAPY WITH HDR BOOST Vigneault, E.
2009
92 S2 p. S2-
1 p.
artikel
43 122 COMPARISON OF HELICAL, SLOW AND AVERAGE CT FOR RADIATION TREATMENT PLANNING AND NORMAL TISSUE CONTOURING IN STEREOTACTIC BODY RADIOTHERAPY OF LUNG TUMOURS Han, K.
2009
92 S2 p. S39-
1 p.
artikel
44 72 CONCOMITANT TREATMENT OF F98 GLIOMA WITH NEW LIPOSOMAL PLATINUM COMPOUNDS AND IONIZING RADIATION Charest, G.
2009
92 S2 p. S23-
1 p.
artikel
45 139 CONCURRENT CHEMOTHERAPY (CHT) AND INTENSITY MODULATED RADIATION THERAPY (IMRT) VERSUS IMRT ALONE FOR THE TREATMENT (TT) OF STAGE (STG) III–IV OROPHARYNGEAL CARCINOMA (OPC): A RETROSPECTIVE STUDY AT THE NOVA SCOTIA CANCER CENTRE (NSCC) Atrchian, S.
2009
92 S2 p. S44-S45
2 p.
artikel
46 44 COPY NUMBER ALTERATION PREDICTS FOR BIOCHEMICAL RECURRENCE IN LOCALIZED PROSTATE CANCER USING HIGHRESOLUTION ARRAY COMPARATIVE GENOMIC HYBRIDIZATION Ishkanian, A.
2009
92 S2 p. S14-S15
2 p.
artikel
47 116 COST ANALYSIS OF STEREOTACTIC BODY RADIATION THERAPY USING DAILY CONE BEAM COMPUTED TOMOGRAPHY FOR EARLY STAGE LUNG CANCER Owen, T.
2009
92 S2 p. S37-
1 p.
artikel
48 112 CROSS-SECTIONAL VALIDATION OF THE PROSTATE CANCER RADIATION THERAPY (PCRT) HRQOL INSTRUMENT VERSUS THE EPIC QUESTIONNAIRE Rodrigues, G.
2009
92 S2 p. S36-
1 p.
artikel
49 155 CURRENT PRACTICE FOR THE PROPHYLAXIS AND MANAGEMENT OF RADIATION INDUCED SKIN REACTIONS Pang, J.
2009
92 S2 p. S49-
1 p.
artikel
50 119 CUTANEOUS MARKERS USED FOR TARGET LOCALIZATION IN ACCELERATED PARTIAL BREAST IRRADIATION (APBI) ARE STRONGLY CORRELATED WITH THE UNDERLYING SURGICAL CAVITY Olson, R.
2009
92 S2 p. S38-
1 p.
artikel
51 108 DECISION AID FOR PATIENTS WITH DUCTAL CARCINOMA IN SITU OF THE BREAST (DCIS) IMPROVES KNOWLEDGE AND REDUCES DECISIONAL CONFLICT: A PILOT STUDY Lo, A.
2009
92 S2 p. S34-S35
2 p.
artikel
52 170 DERIVING PROSTATE ALPHA-BETA RATIO USING CAREFULLY MATCHED GROUPS, LONG FOLLOW UP AND THE PHOENIX DEFINITION OF BIOCHEMICAL FAILURE Shaffer, R.
2009
92 S2 p. S54-
1 p.
artikel
53 50 DETECTION OF CIRCULATING TUMOUR CELLS IN PROSTATE CANCER PATIENTS WITH RISING PSA POST-PROSTATECTOMY Sexton, T.
2009
92 S2 p. S16-
1 p.
artikel
54 17 DETERMINING PATTERNS OF THERAPY CHOICE IN PATIENTS TREATED FOR EARLY STAGE, AGGRESSIVE HISTOLOGY NONHODGKIN'S LYMPHOMA Swaminath, A.
2009
92 S2 p. S6-
1 p.
artikel
55 87 DEVELOPING CONSENSUS AMONG CLINICAL EXPERTS AND NONEXPERTS FOR THE ROLE OF POSITRON EMISSION TOMOGRAPHY IN SMALL CELL LUNG CANCER Ung, Y.C.
2009
92 S2 p. S28-
1 p.
artikel
56 25 DEVELOPMENT AND IMPLEMENTATION OF A CONE BEAM CT (CBCT) ENABLED ONE-STEP SIMULATION AND TREATMENT PROCESS FOR BONE METASTASES (BM) Wong, R.K.S.
2009
92 S2 p. S8-
1 p.
artikel
57 99 DEVELOPMENT OF A CANADIAN PALLIATIVE RADIATION ONCOLOGY CURRICULUM Chung, C.
2009
92 S2 p. S32-
1 p.
artikel
58 26 DEVELOPMENT OF CANADIAN QUALITY INDICATORS FOR RADIOTHERAPY OF LOCALIZED PROSTATE CANCER Danielson, B.
2009
92 S2 p. S9-
1 p.
artikel
59 113 DICHLOROACETATE IN BREAST CANCER: EXPLORING APOPTOSIS AS A POSSIBLE MECHANISM Ko, L.
2009
92 S2 p. S36-
1 p.
artikel
60 98 DOES CURATIVE TREATMENT OF PROSTATE CANCER AFFECT CAUSE-SPECIFIC SURVIVAL? UPDATE FROM THE SASKATCHEWAN PROSTATE CANCER DATABASE Skarsgard, D.
2009
92 S2 p. S31-S32
2 p.
artikel
61 164 DO HIGH PHYSICIAN OFFER RATES IMPROVE RECRUITMENT TO A CLINICAL TRIAL? Parhar, T.
2009
92 S2 p. S52-
1 p.
artikel
62 51 DOSIMETRIC COMPARISON OF BOOST TECHNIQUES FOR ADJUVANT BREAST RADIOTHERAPY Mitera, G.
2009
92 S2 p. S16-S17
2 p.
artikel
63 136 DOSIMETRIC COMPARISON OF DIFFERENT DOSE PRESCRIPTIONS AND BEAM WEIGHTINGS FOR VOLUMETRIC TREATMENT PLANS FOR VERTEBRAL METASTASES Lau, M.
2009
92 S2 p. S43-S44
2 p.
artikel
64 91 DOSIMETRIC EVALUATION OF IMRT TECHNIQUE FOR POSTOPERATIVE PELVIS RADIOTHERAPY (RT) FOR ENDOMETRIAL CANCER Lam, T.
2009
92 S2 p. S29-
1 p.
artikel
65 56 DOSIMETRIC TREATMENT EVALUATION AND OPTIMIZED REPLANNING FOR IMRT OF CERVIX CANCER Stewart, J.
2009
92 S2 p. S18-
1 p.
artikel
66 63 DYSPAREUNIA AFTER CHEMORADIATION (CHEMO-RT) FOR ANAL CARCINOMA -AN UNDER REPORTED COMPLICATION McCarty, H.
2009
92 S2 p. S20-
1 p.
artikel
67 158 EARLY AND LATE SIDE EFFECTS IN PATIENTS WITH OROPHARYNGEAL AND HYPOPHARYNGEAL CANCER TREATED WITH IMRT and CONVENTIONAL 2D RADIOTHERAPY Tayel, A.
2009
92 S2 p. S50-
1 p.
artikel
68 191 EFFECTIVENESS OF BICALUTAMIDE AND DUTASTERIDE FOR PROSTATE VOLUME REDUCTION PRIOR TO PROSTATE BRACHYTHERAPY Wong, J.
2009
92 S2 p. S60-S61
2 p.
artikel
69 174 EFFICACY OF HYPERBARIC OXYGEN THERAPY IN THE TREATMENT OF MEDICALLY REFRACTORY SOFT TISSUE NECROSIS AFTER PENILE BRACHYTHERAPY Gomez-Iturriaga, A.
2009
92 S2 p. S55-
1 p.
artikel
70 43 EFFICACY OF LOW-DOSE INVOLVED-FIELD RADIOTHERAPY FOLLOWING 3-4 CYCLES OF CHEMOTHERAPY FOR PATIENTS WITH STAGE I-II AGGRESSIVE NON-HODGKIN'S LYMPHOMA Gauthier, I.
2009
92 S2 p. S14-
1 p.
artikel
71 123 ESTIMATING PROSTATE VOLUME IN THE RADIATION ONCOLOGY PRACTICE: A COMPARISON BETWEEN TRANSABDOMINAL AND TRANSRECTAL ULTRASOUND Dal Pra, A.
2009
92 S2 p. S39-
1 p.
artikel
72 92 EVALUATION OF A PROTOCOL TO REDUCE RECTAL VOLUME AND PROSTATE MOTION FOR EXTERNAL BEAM RADIATION THERAPY OF THE PROSTATE Darud, M.
2009
92 S2 p. S29-S30
2 p.
artikel
73 121 EVALUATION OF A TEACHING MODEL TO ENHANCE FAMILY PHYSICIAN INVOLVEMENT IN THE DISTRIBUTION OF ADJUVANT AROMATASE INHIBITORS AFTER TAMOXIFEN IN POSTMENOPAUSAL BREAST CANCER PATIENTS IN SOUTHERN ALBERTA Trotter, T.
2009
92 S2 p. S39-
1 p.
artikel
74 195 EVALUATION OF INFRA-HYOID MIDLINE NORMAL STRUCTURE DOSES IN OROPHARYNX SQUAMOUS CELL CANCER TREATED WITH IMRT Morley, L.
2009
92 S2 p. S62-
1 p.
artikel
75 126 FACTORS INFLUENCING DOSE/FRACTIONATION CHOICES FOR PALLIATION OF BONE METASTASES Potter, A.
2009
92 S2 p. S40-
1 p.
artikel
76 84 FACTORS INFLUENCING PROPHYLACTIC CRANIAL IRRADIATION UTILIZATION IN LIMITED STAGE SMALL CELL LUNG CANCER Giuliani, M.
2009
92 S2 p. S27-
1 p.
artikel
77 109 FACTORS INFLUENCING REFERRAL FOR PALLIATIVE RADIOTHERAPY Fairchild, A.
2009
92 S2 p. S35-
1 p.
artikel
78 80 FIVE YEAR REVIEW OF THE NON MELANOMA SKIN CANCER CLINIC AT THE ODETTE CANCER CENTRE Barnes, E.
2009
92 S2 p. S26-
1 p.
artikel
79 42 FUNCTIONAL IMAGING OF NEOADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY IN WOMEN WITH LOCALLY ADVANCED BREAST CANCER (LABC) USING DIFFUSE OPTICAL SPECTROSCOPY Soliman, H.
2009
92 S2 p. S14-
1 p.
artikel
80 194 FUNCTIONAL MAGNETIC RESONANCE IMAGING OF ACOUSTIC NEUROMAS AFTER STEREOTACTIC IRRADIATION Twiss, M.M.J.
2009
92 S2 p. S61-
1 p.
artikel
81 58 GENE EXPRESSION PROFILING IDENTIFIES BIOLOGIC PROCESSES PREDICTIVE OF RADIATION RESPONSE IN PATIENTS WITH ADVANCED CERVICAL CANCER Doll, C.
2009
92 S2 p. S18-S19
2 p.
artikel
82 49 GOLD-NANOPARTICLES SENSITIZE RADIOTHERAPY OF PROSTATE CANCER CELLS BY REGULATION OF CELL CYCLE Roa, W.
2009
92 S2 p. S16-
1 p.
artikel
83 154 HEALTH SYSTEM CHARACTERISTICS ASSOCIATED WITH PATTERNS OF PALLITIVE CARE USE IN ONTARIO Sussman, J.
2009
92 S2 p. S49-
1 p.
artikel
84 129 HIGH INTERSTITIAL FLUID PRESSURE (IFP) AND HYPOXIA ARE BIOMARKERS OF CISPLATIN CHEMO-RADIATION RESPONSE IN ADVANCED CERVIX CANCER Fyles, A.
2009
92 S2 p. S41-
1 p.
artikel
85 73 HIPPOCAMPAL RADIATION EXPOSURE MAY TEMPORARILY IMPAIR MEMORY IN A DOSE-DEPENDENT MANNER IN PATIENTS RECEIVING RADIOSURGERY FOR BENIGN NEUROLOGIC DISORDERS Kong, I.
2009
92 S2 p. S23-S24
2 p.
artikel
86 145 HORMONAL THERAPY IN MANAGING PROSTATE CANCER: A SURVEY OF CANADIAN PATTERNS OF PRACTICE Lian, J.
2009
92 S2 p. S46-
1 p.
artikel
87 189 HOW SPATIAL ACCESSIBILITY TO RADIATION ONCOLOGY SERVICES IN PROSTATE CANCER PATIENTS IN ALBERTA DETERMINES INITIAL TREATMENT CHOICE Kerba, M.
2009
92 S2 p. S60-
1 p.
artikel
88 22 HYPOFRACTIONATED DYNAMIC INTENSITY MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH GLIOBLASTOMA UTILIZING MAGNETIC RESONANCE SPECTROSCOPIC IMAGING TO PREDICT TREATMENT RESPONSE Le, D.
2009
92 S2 p. S7-S8
2 p.
artikel
89 32 HYPOFRACTIONATED RADIATION THERAPY (RT) FOR LOCALIZED PROSTATE CANCER (PC) Rene, N.
2009
92 S2 p. S10-S11
2 p.
artikel
90 132 HYPOFRACTIONATED RADIOTHERAPY FOR LOW RISK PROSTATE CANCER: PRELIMINARY RESULTS OF A PHASE I/II TRIAL Menkarios, C.
2009
92 S2 p. S42-
1 p.
artikel
91 196 HYPOPHARYNX CARCINOMA – REVIEW OF THE PETER MACCALLUM CANCER CENTRE (PMCC) EXPERIENCE Germain, F.
2009
92 S2 p. S62-
1 p.
artikel
92 7 IMAGE GUIDED BRACHYTHERAPY FOR CERVICAL CANCER: A CANADIAN PATTERN OF PRACTICE SURVEY Pavamani, S.
2009
92 S2 p. S2-S3
2 p.
artikel
93 15 IMPACT OF DAILY VOLUMETRIC IMAGING IN REDUCING SET-UP MARGINS FOR LUNG CANCER PATIENTS TREATED WITH CONVENTIONALLY FRACTIONATED RADIOTHERAPY Higgins, J.
2009
92 S2 p. S5-
1 p.
artikel
94 105 IMPACT OF INTERNAL MAMMARY NODE (IMN) INCLUSION IN THE RADIATION TREATMENT VOLUME ON THE OUTCOMES OF BREAST CANCER PATIENTS TREATED WITH LOCOREGIONAL RADIATION Olson, R.
2009
92 S2 p. S33-S34
2 p.
artikel
95 156 IMPACT OF RTT INITIATED BOOKING GUIDELINES ON WAIT TIMES FOR NON MELANOMA SKIN CANCER PATIENTS Breen, D.
2009
92 S2 p. S49-
1 p.
artikel
96 66 IMPACT OF ULTRAHIGH BASELINE PSA LEVELS ON BIOCHEMICAL AND CLINICAL OUTCOMES IN TWO RADIATION THERAPY ONCOLOGY GROUP (RTOG) PROSTATE CANCER (PC) CLINICAL TRIALS Rodrigues, G.
2009
92 S2 p. S21-
1 p.
artikel
97 52 IMPLEMENTATION OF A SEMI-AUTOMATIC VERTEBRA DETECTION AND SEGMENTATION ALGORITHM FOR RADIOTHERAPY OF SPINOUS BONE METASTASES Martin, M.
2009
92 S2 p. S17-
1 p.
artikel
98 11 IMPROVEMENT OF TARGET COVERAGE IN RADICAL LUNG RADIOTHERAPY USING IMAGE GUIDANCE CONE-BEAM CT (CBCT) Lavoie, C.
2009
92 S2 p. S4-
1 p.
artikel
99 24 IMPROVING CARE BEYOND CURE – THE ROLE OF AN ADULT RADIATION LATE EFFECTS CLINIC (ARLEC) McCarty, H.
2009
92 S2 p. S8-
1 p.
artikel
100 184 INCLUSION OF SPECT PERFUSION IMAGES IN THE INVERSE PLANNING OF LUNG CANCER St-Hilaire, J.
2009
92 S2 p. S58-
1 p.
artikel
101 101 INDUCTION CHEMOTHERAPY FOLLOWED BY LOCOREGIONAL TREATMENT IN T4 OR N3 HEAD AND NECK SQUAMOUS CELL CARCINOMA: A SINGLE INSTITUTION EXPERIENCE Delouya, G.
2009
92 S2 p. S32-
1 p.
artikel
102 79 INFLUENCE OF PET/CT SCAN ON PRE-TREATMENT CLINICAL DECISION-MAKING IN PATIENTS DIAGNOSED WITH NON-SMALL CELL LUNG CANCER AT THE BRITISH COLUMBIA CANCER AGENCY Mohamed, I.G.
2009
92 S2 p. S25-S26
2 p.
artikel
103 37 INTENSITY MODULATED RADIATION THERAPY (IMRT) FOR SKULL BASE CHORDOMAS AND CHONDROSARCOMAS: OUTCOMES IN THE IMAGE GUIDED ERA Bahl, G.
2009
92 S2 p. S12-
1 p.
artikel
104 182 INTENSITY MODULATED RADIOTHERAPY (IMRT) AND CONCURRENT CHEMOTHERAPY (CHT) FOR ANAL AND PERIANAL CANCER: PRELIMINARY REPORT OF ACUTE TOXICITY Han, K.
2009
92 S2 p. S58-
1 p.
artikel
105 70 INTERIM TOXICITY OF THE ELDORADO STUDY: A PHASE II STUDY OF CONCURRENT WEEKLY DOCETAXEL, IMRT AND LONG-TERM ANDROGEN DEPRIVATION (CLINICALTRIALS.GOV ID: NCT00452556) Wilke, D.
2009
92 S2 p. S22-S23
2 p.
artikel
106 176 INTER-OBSERVER AND INTRA-OBSERVER IN PRIMARY TUMOUR AND INVOLVED NODAL VOLUME DELINEATION IN THE 4DCT ERA Louie, A.
2009
92 S2 p. S56-
1 p.
artikel
107 183 INTRAOPERATIVE POSTIMPLANT DOSIMETRY USING TOMOSYNTHESIS IN LOW-DOSE RATE PROSTATE BRACHYTHERAPY Carrier, J-F.
2009
92 S2 p. S58-
1 p.
artikel
108 93 INVESTIGATION OF TWO COGNITIVE SCREENING MEASURES: DIAGNOSTIC ACCURACY AND CORRELATION WITH QUALITY OF LIFE AND MEASURES OF COMMUNITY INTEGRATION Olson, R.
2009
92 S2 p. S30-
1 p.
artikel
109 39 IN VITRO AND IN VIVO VASCULAR EFFECTS OF NOVEL RADIOSENSITIZING ULTRASOUND-ACTIVATED MICROBUBBLES Caissie, A.
2009
92 S2 p. S13-
1 p.
artikel
110 1 125-IODINE PROSTATE BRACHYTHERAPY (BT) AS MONOTHERAPY IN PATIENTS AGED 55 YEARS OR LESS WITH LOCALIZED PROSTATE CANCER Gomez-Iturriaga, A.
2009
92 S2 p. S1-
1 p.
artikel
111 46 IONIZING RADIATION ACTIVATES AMP – ACTIVATED PROTEIN KINASE (AMPK) IN HUMAN EPITHELIAL TUMOUR CELLS THROUGH AN LKB1-INDEPENDENT AND ATM-DEPENDENT PATHWAY Tsakiridis, T.
2009
92 S2 p. S15-
1 p.
artikel
112 178 IS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY (CTRT) IN ELDERLY HEAD AND NECK PATIENTS A REASONABLE AND SAFE APPROACH? THE NOTRE-DAME HOSPITAL EXPERIENCE Mehiri, S.
2009
92 S2 p. S56-
1 p.
artikel
113 60 IS CONTEMPORARY MANAGEMENT OF CERVIX CANCER IMPROVING OUTCOMES? Kobeleva, S.
2009
92 S2 p. S19-
1 p.
artikel
114 143 ISOLATED PELVIC NODAL RECURRENCES AFTER CHEMORADIATION THERAPY FOR CERVICAL CANCER: IMPLICATIONS FOR PRACTICE Aquino-Parsons, C.
2009
92 S2 p. S46-
1 p.
artikel
115 172 IS THERE AN ADVANTAGE TO IMRT FOR HARD TO TREAT PRIMARY BRAIN CANCER? Follwell, M.
2009
92 S2 p. S54-S55
2 p.
artikel
116 4 LAPAROSCOPIC GUIDANCE FOR GYNECOLOGIC INTERSTITIAL BRACHYTHERAPY IMPLANTS Wiebe, E.
2009
92 S2 p. S2-
1 p.
artikel
117 74 LATE ENDOCRINE TOXICITY OF RADIATION THERAPY IN CHILDREN TREATED FOR MEDULLOBLASTOMA OR EPENDYMOMA Bahl, G.
2009
92 S2 p. S24-
1 p.
artikel
118 59 LONG-TERM TOXICITY FOLLOWING DEFINITIVE RADIOTHERAPY TO PELVIS OR PELVIS AND PARAAORTIC LYMPH NODES IN COMBINATION WITH CONCURRENT CHEMOTHERAPY FOR CERVICAL CANCER PATIENTS Yan, J.
2009
92 S2 p. S19-
1 p.
artikel
119 90 LYMPHOEPITHELIAL CARCINOMA OF THE MAJOR SALIVARY GLANDS: A PROVINCIAL REVIEW OF TREATMENT OUTCOMES Fua, T.
2009
92 S2 p. S29-
1 p.
artikel
120 114 MANAGEMENT OF PITUITARY ADENOMA WITH STEREOTACTIC RADIOTHERAPY AT PRINCESS MARGARET HOSPITAL Patil, N.
2009
92 S2 p. S36-S37
2 p.
artikel
121 137 MEASURING RADIATION THERAPY TREATMENT PLANNING FOR PERFORMANCE AND WORKLOAD OUTCOME Darud, SM.
2009
92 S2 p. S44-
1 p.
artikel
122 94 MEASURING THE PATIENT EXPERIENCE – RESULTS OF A RADIATION THERAPY PATIENT SATISFACTION SURVEY FROM 2004-2008 French, J.
2009
92 S2 p. S30-
1 p.
artikel
123 48 NON-INVASIVE ULTRASOUND MONITORING OF RADIATION AND VASCULAR DISRUPTING MICROBUBBLE TREATMENT EFFECTS Lee, J.
2009
92 S2 p. S15-S16
2 p.
artikel
124 160 ONCOLOGIST CASE LOAD VOLUME AND DISEASE OUTCOMES AFTER CURATIVE EXTERNAL BEAM RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER Stokes, E.
2009
92 S2 p. S51-
1 p.
artikel
125 149 OPTIMAL IMRT FLUENCE SMOOTHING TO REDUCE MONITOR UNITS (MU) Cao, F.
2009
92 S2 p. S47-S48
2 p.
artikel
126 163 OUTCOMES AND PREDICTORS OF SURVIVAL FOLLOWING CONCOMITANT AND ADJUVANT TEMOZOLOMIDE WITH RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME Swaminath, A.
2009
92 S2 p. S52-
1 p.
artikel
127 95 OUTCOMES FOR PATIENTS WITH INOPERABLE EARLY STAGE NON-SMALL LUNG CANCER IN THE 3D PLANNING ERA Smith, S.
2009
92 S2 p. S30-S31
2 p.
artikel
128 128 OUTCOMES OF STAGE I/II, GRADE 3 ENDOMETRIAL ADENOCARCINOMA TREATED WITH ADJUVANT INTRAVAGINAL BRACHYTHERAPY ALONE AFTER SURGICAL STAGING FROM 1995–2006 Cuartero, J.F.
2009
92 S2 p. S41-
1 p.
artikel
129 38 OUTCOMES OF YOUNG WOMEN WITH DCIS TREATED WITH BREAST-CONSERVING SURGERY AND RADIOTHERAPY: A POPULATION-BASED ANALYSIS Kong, I.
2009
92 S2 p. S12-S13
2 p.
artikel
130 179 PALLIATIVE RADIOTHERAPY FOR HEAD AND NECK CANCER: A RETROSPECTIVE, SINGLE-INSTITUTIONAL REVIEW Stevens, C.M.
2009
92 S2 p. S57-
1 p.
artikel
131 28 PATTERNS OF CARE IN ELDERLY HEAD AND NECK CANCER PATIENTS: A SINGLE INSTITUTION RECENT EXPERIENCE Huang, S.H.
2009
92 S2 p. S9-
1 p.
artikel
132 81 PATTERNS OF FAILURE IN PATIENTS WITH ANAL CANAL CARCINOMA TREATED WITH 3-D BASED RADIOTHERAPY USING CONFORMAL THERAPY 3D-CRT) OR INTENSITY MODULATED RADIATION THERAPY (IMRT) IN COMBINATION WITH CHEMOTHERAPY Cuthbert, D.
2009
92 S2 p. S26-
1 p.
artikel
133 18 PATTERNS OF RELAPSE AMONG EARLY STAGE HODGKIN'S LYMPHOMA PATIENTS Singh, R.
2009
92 S2 p. S6-
1 p.
artikel
134 64 PELVIC RADIATION IN PATIENTS WITH A PELVIC KIDNEY: NO LONGER PLAYING WITH FIRE Berlach, D.
2009
92 S2 p. S20-S21
2 p.
artikel
135 30 PET START: THE FIRST RANDOMIZED CLINICAL TRIAL EVALUATING THE IMPACT OF POSITRON EMISSION TOMOGRAPHY IN STAGE III NON-SMALL CELL LUNG CANCER Ung, Y.C.
2009
92 S2 p. S10-
1 p.
artikel
136 77 PHASE 1 DOSE ESCALATION TRIAL OF LIMITED FIELD HYPOFRACTIONATED THORACIC RADIOTHERAPY FOR LIMITED STAGE SMALL CELL LUNG CANCER Yee, D.
2009
92 S2 p. S25-
1 p.
artikel
137 96 PHASE II TRIAL OF CONSOLIDATION CHEST RADIOTHERAPY FOR EXTENSIVE STAGE SMALL CELL LUNG CANCER Yee, D.
2009
92 S2 p. S31-
1 p.
artikel
138 193 PHOTODYNAMIC THERAPY AS A TREATMENT OPTION FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE LOWER EXTREMITY Vujovic, O.
2009
92 S2 p. S61-
1 p.
artikel
139 171 PILOT STUDY OF PRE OPERATIVE INVOLVED FIELD RADIOTHERAPY FOR RECTAL CANCER Severin, D.
2009
92 S2 p. S54-
1 p.
artikel
140 144 PLANNING RESOURCE OPTIMIZATION USING IMRT FOR PROSTATE CANCER Cao, F.
2009
92 S2 p. S46-
1 p.
artikel
141 148 POST OPERATIVE RADIATION THERAPY (RT) AFTER HIP REPLACEMENT IN HIGH RISK PATIENTS FOR DEVELOPMENT OF HETEROTOPIC BONE FORMATION (HBF) Hashem, R.
2009
92 S2 p. S47-
1 p.
artikel
142 41 PREDICTIVE FACTORS FOR SEVERE LATE TOXICITY AFTER THORACIC CHEST WALL REIRRADIATION Kim, S.
2009
92 S2 p. S13-S14
2 p.
artikel
143 75 PRELIMINARY REPORT OF PROSTATE PET IMAGING USING 11C – CHOLINE BEFORE, DURING AND AFTER RADIOTHERAPY Amanie, J.
2009
92 S2 p. S24-
1 p.
artikel
144 86 PRELIMINARY RESULTS ON TOXICITY AND QUALITY OF LIFE AFTER STEREOTACTIC BODY RADIATION THERAPY FOR STAGE I NON-SMALL CELL LUNG CANCER: A SINGLE INSTITUTION PROSPECTIVE TRIAL Owen, T.
2009
92 S2 p. S28-
1 p.
artikel
145 130 PRE-OPERATIVE INTENSITY MODULATED RADIATION THERAPY (IMRT) IN RETROPERITONEAL SARCOMA TREATMENT: THE CHUM EXPERIENCE Mehiri, S.
2009
92 S2 p. S41-S42
2 p.
artikel
146 85 PRE-RADIATION TREATMENT PET/CT SCAN CAN PREDICT THE LOCALIZATION OF RESIDUAL DISEASE POST-TREATMENT IN LUNG CANCER Lavoie, C.
2009
92 S2 p. S27-
1 p.
artikel
147 115 PREVALENCE OF NEUROPATHIC PAIN SYMPTOMS IN PATIENTS WITH CANCER BONE PAIN REFERRED FOR PALLIATIVE RADIOTHERAPY Kerba, M.
2009
92 S2 p. S37-
1 p.
artikel
148 40 PRIMARY MALTOMA OF THE ORBIT AND SYSTEMIC MALT DISEASE Owen, D.
2009
92 S2 p. S13-
1 p.
artikel
149 131 PRIMARY MULTI-MODALITY BLADDER-PRESERVING THERAPY FOR LOCALLY-ADVANCED BLADDER CANCER Dennis, K.
2009
92 S2 p. S42-
1 p.
artikel
150 12 PRINCESS MARGARET HOSPITAL EXPERIENCE WITH LUNG STEREOTACTIC BODY RADIOTHERAPY FOR EARLY STAGE NONSMALL CELL LUNG CANCER Taremi, M.
2009
92 S2 p. S4-
1 p.
artikel
151 153 PROSPECTIVE ASSESSMENT OF AN OUTPATIENT PALLIATIVE CARE INTERVENTION IN PATIENTS WITH METASTATIC CANCER Follwell, M.
2009
92 S2 p. S48-S49
2 p.
artikel
152 76 PROSPECTIVE STUDY EVALUATING SALVAGE RADIOTHERAPY (RT) PLUS 2-YEAR ANDROGEN SUPPRESSION (AS) FOR POST-RADICAL PROSTATECTOMY PATIENTS WITH PSA RELAPSE Choo, R.
2009
92 S2 p. S24-S25
2 p.
artikel
153 111 PROSTATE BRACHYTHERAPY: NOMOGRAM COMPARISON WITH SURGICAL OUTCOME Pickles, T.
2009
92 S2 p. S35-S36
2 p.
artikel
154 35 PROSTATE CANCER HYPOXIA PREDICTS EARLY BIOCHEMICAL FAILURE AFTER RADIOTHERAPY Milosevic, M.
2009
92 S2 p. S11-S12
2 p.
artikel
155 197 PROSTATE EDEMA AFTER FIDUCIAL MARKER IMPLANTATION Derashodian, T.
2009
92 S2 p. S62-
1 p.
artikel
156 134 QUALITY OF LIFE MEASURES USED IN RADIATION THERAPY TRIALS FOR METASTATIC SPINAL CORD COMPRESSION (MSCC) PATIENTS: A LITERATURE REVIEW Mitera, G.
2009
92 S2 p. S43-
1 p.
artikel
157 168 QUALITY OF LIFE OF PATIENTS RECEIVING STEROIDS AND OPTIMAL SUPPORTIVE CARE WITH OR WITHOUT WHOLE BRAIN RADIOTHERAPY IN THE TREATMENT OF INOPERABLE BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER: THE MRC QUARTZ RANDOMIZED TRIAL Barton, R.
2009
92 S2 p. S53-
1 p.
artikel
158 117 QUANTITATIVE ENDOSCOPY FOR IMPROVED TARGET DELINEATION IN PLANNING INTENSITY MODULATED RADIATION THERAPY FOR HEAD AND NECK CANCER Weersink, R.
2009
92 S2 p. S37-S38
2 p.
artikel
159 100 RADIATION THERAPY PERFORMANCE INDICATORS – MEASURING PRODUCTIVITY OF A RADIATION THERAPY DEPARTMENT French, J.
2009
92 S2 p. S32-
1 p.
artikel
160 138 RADIATION TREATMENT PLANNING WITH POSITRON EMISSION TOMOGRAPHY (PET) COREGISTERED WITH CT MAY ALTER RECURRENCE PATTERNS AS COMPARED WITH CT PLANNING ALONE FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER Chan, E.
2009
92 S2 p. S44-
1 p.
artikel
161 88 REACTIVE NASOGASTRIC FEEDING TUBE IS ASSOCIATED WITH LOW MORBIDITY AND MORTALITY IN CHEMORADIATION FOR ADVANCED HEAD AND NECK CANCER Clavel, S.
2009
92 S2 p. S28-
1 p.
artikel
162 123 ROLE OF RADIATION INDUCED ß1-INTEGRIN EXPRESSION IN TRASTUZUMAB RESISTANCE IN HER-2 POSITIVE BREAST CANCER Thoms, J.
2009
92 S2 p. S63-
1 p.
artikel
163 14 SCREENING LUNG CANCER WITH MIRNA EXPRESSION PROFILES Roa, W.
2009
92 S2 p. S5-
1 p.
artikel
164 124 SEMI-AUTOMATIC DELINEATION OF PELVIC LYMPH NODE CLINICAL TARGET VOLUME (CTV-PLN) FOR PROSTATE CANCER Bayley, A.
2009
92 S2 p. S39-S40
2 p.
artikel
165 21 SIGNIFICANT LATE TOXICITIES ASSOCIATED WITH STEREOTACTIC RADIOTHERAPY FOR JUXTAPAPILLARY CHOROIDAL MELANOMA Sahgal, A.
2009
92 S2 p. S7-
1 p.
artikel
166 34 SINGLE FRACTION HIGH DOSE RATE BRACHYTHERAPY AND HYPOFRACTIONATED EXTERNAL BEAM RADIATION THERAPY IN THE TREATMENT OF LOCALIZED PROSTATE CANCER Cury, F.
2009
92 S2 p. S11-
1 p.
artikel
167 62 SINGLE FRACTION STEREOTACTIC BODY RADIATION THERAPY (SBRT) AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER Schellenberg, D.
2009
92 S2 p. S20-
1 p.
artikel
168 68 SPATIAL PATTERNS OF LOCAL RECURRENCE AFTER RADIOTHERAPY FOR PROSTATE CANCER Chopra, S.
2009
92 S2 p. S22-
1 p.
artikel
169 104 SPINAL CORD TOLERANCE FOR STEREOTACTIC BODY RADIOTHERAPY Sahgal, A.
2009
92 S2 p. S33-
1 p.
artikel
170 83 STEREOTACTIC RADIOSURGERY FOR INTRACRANIAL ARTERIOVENOUS MALFORMATIONS AT THE BRITISH COLUMBIA CANCER AGENCY Hsu, F.
2009
92 S2 p. S27-
1 p.
artikel
171 165 SURVIVORS OF BREAST CANCER: IMPACTS OF TREATMENT AND PREFERENCES FOR SURVIVORSHIP CARE PLANNING AT DIFFERENT LIFE STAGES Smith, S.
2009
92 S2 p. S52-
1 p.
artikel
172 147 SYMPTOM CONTROL AND QUALITY OF LIFE ABSTRACTS PRESENTED AT CANADIAN ASSOCIATION OF RADIATION ONCOLOGY ANNUAL MEETINGS: 2003 TO 2008 Cuartero, J.F.
2009
92 S2 p. S47-
1 p.
artikel
173 13 SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF PET IN STAGING OF NON-SMALL CELL LUNG CANCER (NSCLC) AND MANAGEMENT OF SOLITARY PULMONARY NODULES Cao, J.
2009
92 S2 p. S4-S5
2 p.
artikel
174 6 TARGET AND OAR VOLUME CHANGE DURING IMAGE GUIDED PULSED-DOSE-RATE (PDR) BRACHYTHERAPY (BT) FOR CERVIX CANCER Xie, X.
2009
92 S2 p. S2-
1 p.
artikel
175 177 TEMPORAL LUNG TUMOUR VOLUME CHANGES IN SMALL CELL LUNG CANCER PATIENTS UNDERGOING CHEMORADIOTHERAPY Yee, D.
2009
92 S2 p. S56-
1 p.
artikel
176 127 THE CHANGING PATTERN OF HEAD AND NECK CANCER INCIDENCE IN BRITISH COLUMBIA (BC) 1980 – 2006 Hay, J.
2009
92 S2 p. S40-S41
2 p.
artikel
177 188 THE CLINICAL IMPACT OF VARIATION IN CLINICAL TARGET VOLUMES FOR POST-PROSTATECTOMY PATIENTS Lock, M.
2009
92 S2 p. S59-S60
2 p.
artikel
178 45 THE EFFECTIVENESS OF WEB-BASED ANATOMY INSTRUCTION IN RADIATION ONCOLOGY Alfieri, J.
2009
92 S2 p. S15-
1 p.
artikel
179 61 THE EFFECT OF DNA-PK INHIBITION ON RADIOMODULATION AND CELL CYCLE DISTRIBUTION ON GASTRIC CANCER: PRELIMINARY RESULTS Mok, G.
2009
92 S2 p. S19-S20
2 p.
artikel
180 159 THE FEASIBILITY AND IMPACT OF INCREASING THE EXTERNAL BEAM COMPONENT OF RADIATION THERAPY (RT) IN CERVIX CANCER PATIENTS USING DYNAMIC HELICAL IMRT, PLANNED WITH MRI/CT FUSION Chowdhury, R.
2009
92 S2 p. S50-S51
2 p.
artikel
181 54 THE IMPACT OF CONTOURING SPECIALISTS ON THE PROCESS OF HEAD AND NECK IMRT TREATMENT PLANNING Chan, H.B.
2009
92 S2 p. S17-S18
2 p.
artikel
182 9 THE IMPACT OF PERINEURAL INVASION (PNI) ON BIOCHEMICAL OUTCOME FOLLOWING 125I PROSTATE BRACHYTHERAPY Gomez-Iturriaga, A.
2009
92 S2 p. S3-
1 p.
artikel
183 180 THE PATTERN OF RECURRENCE AFTER IMRT AND CONVENTIONAL 2D RADIOTHERAPY IN PATIENTS WITH OROPHARYNGEAL AND HYPOPHARYNGEAL CANCER Tayel, A.
2009
92 S2 p. S57-
1 p.
artikel
184 162 THE PREDICTIVE VALUE OF P53 AND P16 EXPRESSION IN PATIENTS WITH CARCINOMA OF THE ANAL CANAL Doll, C.
2009
92 S2 p. S51-
1 p.
artikel
185 102 THE PROGNOSTIC VALUE OF P16 STATUS IN ADVANCED STAGE OROPHARYNGEAL CARCINOMA ACCORDING TO TREATMENT REGIME Goulart, J.
2009
92 S2 p. S33-
1 p.
artikel
186 157 THE ROLE OF 18F-FAZA COMBINED WITH 18F-FDG IN ASSESSING RESPONSE IN PATIENTS WITH INOPERABLE NON-SMALL CELL LUNG CANCER UNDERGOING RADIOTHERAPY OR CHEMORADIOTHERAPY Small, C.
2009
92 S2 p. S50-
1 p.
artikel
187 23 THE TAP STUDY: A PHASE I STUDY DESIGN TO SCREEN FOR UNEXPECTED AND/OR SEVERE INTERACTION BETWEEN RADIATION AND SYSTEMIC AGENTS Brade, A.
2009
92 S2 p. S8-
1 p.
artikel
188 89 THE USE OF AN AUTOMATED SEGMENTATION ALGORITHM AS A METHOD FOR WHOLE TUMOUR ROI DEFINITION TO IMPROVE THE ACCURACY AND STABILITY OF INTRA-TREATMENT FDG ASSESSMENT IN HEAD AND NECK CANCER Vena, D.
2009
92 S2 p. S28-S29
2 p.
artikel
189 185 THE USE OF 4D CT SCANNING IN RADICAL RADIOTHERAPY FOR LUNG CANCER Huang, V.
2009
92 S2 p. S59-
1 p.
artikel
190 27 TIME INTERVALS FROM REFERRAL TO CONSULT AND TIME TO RADIOTHERAPY IN A CANADIAN PROVINCE FROM 1984 TO 2006 Tyldesley, S.
2009
92 S2 p. S9-
1 p.
artikel
191 150 TOMOTHERAPY IN THE TREATMENT OF ANAL CANCER: ACUTE TOXICITY DATA Loewen, S.
2009
92 S2 p. S48-
1 p.
artikel
192 151 TREATMENT PLANNING WITH VOLUMETRIC MODULATED ARC THERAPY FOR STEREOTACTIC BODY RADIOTHERAPY (SBRT) OF SPINAL/PARASPINAL TUMOURS Marchand, E.L.
2009
92 S2 p. S48-
1 p.
artikel
193 181 ULTRASOUND IMAGE GUIDED RADIOTHERAPY (RT): POSTERIOR DISPLACEMENT OF THE PROSTATE (PST) INDUCED BY THE ULTRASOUND (US) PROBE IN PATIENTS WITH A DISTENDED RECTUM Rene, N.
2009
92 S2 p. S57-
1 p.
artikel
194 97 UPDATED RESULTS AND QUALITY OF LIFE ANALYSIS OF COMBINED HYPO-FRACTIONATED RADIATION AND HORMONE THERAPY FOR INTERMEDIATE RISK PROSTATE CANCER Roux, A.
2009
92 S2 p. S31-
1 p.
artikel
195 142 VAGINAL VAULT BRACHYTHERAPY ALONE AS ADJUVANT TREATMENT FOR NODE-NEGATIVE STAGE II ENDOMETRIAL CANCER – MANITOBA EXPERIENCE Ong, A.
2009
92 S2 p. S45-S46
2 p.
artikel
196 47 VALIDATION OF IN VITRO ASSAYS FOR PREDICTING CLINICAL RADIOSENSITIVITY Murray, D.
2009
92 S2 p. S15-
1 p.
artikel
197 69 VOLUMETRIC MODULATED ARC THERAPY (VMAT) AND CONVENTIONAL IMRT FOR SIMULTANEOUS MAXIMAL INTRAPROSTATIC BOOST Shaffer, R.
2009
92 S2 p. S22-
1 p.
artikel
198 190 WHAT FACTORS PREDICT OUTCOME AT RELAPSE AFTER PREVIOUS ESOPHAGECTOMY AND ADJUVANT THERAPY IN HIGH RISK ESOPHAGEAL CANCER? Yu, E.
2009
92 S2 p. S60-
1 p.
artikel
199 187 WHEN SHOULD PATIENTS HAVE THEIR PLANNING CT SCAN AFTER FIDUCIAL MARKER INSERTION FOR PROSTATE CANCER RADIOTHERAPY? Delouya, G.
2009
92 S2 p. S59-
1 p.
artikel
200 8 10-YEAR EXPERIENCE WITH IODINE-125 PROSTATE BRACHYTHERAPY AT PRINCESS MARGARET HOSPITAL Crook, J.
2009
92 S2 p. S3-
1 p.
artikel
                             200 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland